These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6310077)
1. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung. Wiersma DA; Roth RA J Pharmacol Exp Ther; 1983 Sep; 226(3):661-7. PubMed ID: 6310077 [TBL] [Abstract][Full Text] [Related]
2. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity. Wiersma DA; Roth RA J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370 [TBL] [Abstract][Full Text] [Related]
3. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data. Wiersma DA; Roth RA Mol Pharmacol; 1983 Sep; 24(2):300-8. PubMed ID: 6310365 [TBL] [Abstract][Full Text] [Related]
4. The fate of intratracheally installed benzo(a)pyrene in the isolated perfused rat lung of both control and 20-methylcholanthrene pretreated rats. Vainio H; Uotila P; Hartiala J; Pelkonen O Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):259-71. PubMed ID: 1257613 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of nicotine on benzo(a)pyrene elimination and marked pulmonary metabolism of nicotine in isolated perfused rat lung. Foth H; Rüdell U; Ritter G; Kahl GF Klin Wochenschr; 1988; 66 Suppl 11():98-104. PubMed ID: 3184783 [TBL] [Abstract][Full Text] [Related]
6. Benzo(a)pyrene disposition and metabolism in rats following intratracheal instillation. Weyand EH; Bevan DR Cancer Res; 1986 Nov; 46(11):5655-61. PubMed ID: 3756912 [TBL] [Abstract][Full Text] [Related]
7. Covalent binding of benzo(a)pyrene in perfused rat lung following systemic and intratracheal administration. Foth H; Mollière M; Kahl R; Jähnchen E; Kahl GF Drug Metab Dispos; 1984; 12(6):760-6. PubMed ID: 6150827 [TBL] [Abstract][Full Text] [Related]
8. Benzo(a)pyrene phenol production by perfused rat liver and its inhibition by ethanol. Reinke LA; McManus P; Kauffman FC; Thurman RG Cancer Res; 1982 May; 42(5):1681-5. PubMed ID: 6279282 [TBL] [Abstract][Full Text] [Related]
9. [Studies on the induction by extracts from airborne particulates of benzo(a)pyrene hydroxylase and the binding of benzo(a)pyrene to DNA in the rat lung in vivo after pertracheal administration (author's transl)]. Dehnen W; Verbücheln J Zentralbl Bakteriol Mikrobiol Hyg B; 1981 Dec; 174(3):260-73. PubMed ID: 6277103 [TBL] [Abstract][Full Text] [Related]
10. In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism. Klippert PJ; Littel RJ; Noordhoek J J Pharmacol Exp Ther; 1983 Apr; 225(1):153-7. PubMed ID: 6834267 [TBL] [Abstract][Full Text] [Related]
11. Biochemistry, physiology and drug metabolism--implications regarding the role of the lungs in drug disposition. Roth RA Clin Physiol Biochem; 1985; 3(2-3):66-79. PubMed ID: 3891197 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene. Groen K; Breimer DD; van Bezooijen CF Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725 [TBL] [Abstract][Full Text] [Related]
13. Uptake and excretion of benzo[a]pyrene and its metabolites by the rat pancreas. Iqbal ZM; Yoshida A; Epstein SS Drug Metab Dispos; 1979; 7(1):44-8. PubMed ID: 35326 [TBL] [Abstract][Full Text] [Related]
14. Pancreatic metabolism of benzo(a)pyrene in vitro and in vivo in the Long-Evans rat. Black O; Murrill E; Pallas F Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):291-307. PubMed ID: 7414050 [TBL] [Abstract][Full Text] [Related]
15. Ovotoxicity in female Fischer rats and B6 mice induced by low-dose exposure to three polycyclic aromatic hydrocarbons: comparison through calculation of an ovotoxic index. Borman SM; Christian PJ; Sipes IG; Hoyer PB Toxicol Appl Pharmacol; 2000 Sep; 167(3):191-8. PubMed ID: 10986010 [TBL] [Abstract][Full Text] [Related]
16. Influence of red blood cells, serum albumin, and serum lipoproteins on the clearance of benzo[alpha]pyrene by isolated livers of 3-methylcholanthrene-treated rats. Wiersma DA; Stemmer PM; Roth RA Biochem Pharmacol; 1984 Nov; 33(21):3433-8. PubMed ID: 6497903 [TBL] [Abstract][Full Text] [Related]
17. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice. Kulkarni MS; Anderson MW Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174 [TBL] [Abstract][Full Text] [Related]
18. Carcinogenesis, benzo[a]pyrene metabolism, and sister chromatid exchanges in lungs of rats after intratracheal 3-methylcholanthrene. Rasmussen RE; Anderson J; Kinkead ER; MacEwen JD; Bruner RH J Natl Cancer Inst; 1984 Jul; 73(1):257-64. PubMed ID: 6330422 [TBL] [Abstract][Full Text] [Related]
19. The influence of flow on the metabolism of perfused benzo[a]pyrene by isolated rat lung. Wiersma DA; Braselton WE; Roth RA Chem Biol Interact; 1983 Jan; 43(1):1-15. PubMed ID: 6295648 [TBL] [Abstract][Full Text] [Related]
20. Prediction of pulmonary benzo(a)pyrene 4,5-oxide clearance: a pharmacokinetic analysis of epoxide-metabolizing enzymes in rabbit lung. Smith BR; Bend JR J Pharmacol Exp Ther; 1980 Sep; 214(3):478-82. PubMed ID: 7190605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]